Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Mainwaring

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Oncology|July 25, 2009
Phase IV study of bevacizumab in combination with infusional fluorouracil, leucovorin and irinotecan (FOLFIRI) in first-line metastatic colorectal cancerAlberto Sobrero, Stephen Ackland, Stephen Clarke, et al.
Cancer|January 14, 2009
A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanomaAhmad A Tarhini, Michael Millward, Paul Mainwaring, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2016
Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final ResultsSimon J Harrison, Paul Mainwaring, Timothy Price, et al.
Biosensors & Bioelectronics|December 17, 2016
Detection of aberrant protein phosphorylation in cancer using direct gold-protein affinity interactionsMostak Ahmed, Laura G Carrascosa, Abu Ali Ibn Sina, et al.
Asia-Pacific Journal of Clinical Oncology|June 23, 2018
nab-Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trialRosemary Young, Paul Mainwaring, Philip Clingan, et al.
Breast Cancer Research and Treatment|August 9, 2012
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancerRichard H De Boer, Dusan Kotasek, Shane White, et al.
Analytical Chemistry|May 24, 2023
Liquid Biopsy Snapshots of Key Phosphoproteomic Pathways in Lung Cancer Patients for Diagnosis and Therapy MonitoringMostak Ahmed, Alain Wuethrich, Nicolas Constantin, et al.
Asia-Pacific Journal of Clinical Oncology|May 7, 2014
Systemic treatment of HER2-positive metastatic breast cancer: a systematic reviewNicholas Wilcken, Nicholas Zdenkowski, Michelle White, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2020
Efficacy and Safety Exposure-Response Relationships of Apalutamide in Patients with Nonmetastatic Castration-Resistant Prostate CancerCarlos Perez-Ruixo, Oliver Ackaert, Daniele Ouellet, et al.
Asia-Pacific Journal of Clinical Oncology|March 1, 2014
Sunitinib in metastatic renal cell carcinoma: an ethnic Asian subpopulation analysis for safety and efficacySe-Hoon Lee, Yung-Jue Bang, Paul Mainwaring, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Oncology|July 25, 2009
Phase IV study of bevacizumab in combination with infusional fluorouracil, leucovorin and irinotecan (FOLFIRI) in first-line metastatic colorectal cancerAlberto Sobrero, Stephen Ackland, Stephen Clarke, et al.
Cancer|January 14, 2009
A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanomaAhmad A Tarhini, Michael Millward, Paul Mainwaring, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2016
Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final ResultsSimon J Harrison, Paul Mainwaring, Timothy Price, et al.
Biosensors & Bioelectronics|December 17, 2016
Detection of aberrant protein phosphorylation in cancer using direct gold-protein affinity interactionsMostak Ahmed, Laura G Carrascosa, Abu Ali Ibn Sina, et al.
Asia-Pacific Journal of Clinical Oncology|June 23, 2018
nab-Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trialRosemary Young, Paul Mainwaring, Philip Clingan, et al.
Breast Cancer Research and Treatment|August 9, 2012
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancerRichard H De Boer, Dusan Kotasek, Shane White, et al.
Analytical Chemistry|May 24, 2023
Liquid Biopsy Snapshots of Key Phosphoproteomic Pathways in Lung Cancer Patients for Diagnosis and Therapy MonitoringMostak Ahmed, Alain Wuethrich, Nicolas Constantin, et al.
Asia-Pacific Journal of Clinical Oncology|May 7, 2014
Systemic treatment of HER2-positive metastatic breast cancer: a systematic reviewNicholas Wilcken, Nicholas Zdenkowski, Michelle White, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2020
Efficacy and Safety Exposure-Response Relationships of Apalutamide in Patients with Nonmetastatic Castration-Resistant Prostate CancerCarlos Perez-Ruixo, Oliver Ackaert, Daniele Ouellet, et al.
Asia-Pacific Journal of Clinical Oncology|March 1, 2014
Sunitinib in metastatic renal cell carcinoma: an ethnic Asian subpopulation analysis for safety and efficacySe-Hoon Lee, Yung-Jue Bang, Paul Mainwaring, et al.
Pageof 4